Is Micron’s AI boom sustainable? Explore why its low forward P/E may signal a cyclical peak, not value, and why investors ...

The Third Avenue Real Estate Value Fund has generated an annualized return of +8.18% since its inception in 1998 (after fees) ...

Bon Secours nears a $6 billion Surgery Partners deal, signaling outpatient healthcare consolidation and a potential 25% premium for shareholders.

Q drop looks overdone. Click for why AI-driven ad growth, easing cost fears, and attractive valuation make META a Strong Buy ...

Trade negotiations between the United States and Canada are accelerating, with White House economic adviser Kevin Hassett suggesting the two countries are approaching an agreement that could ease ...

Lam Research Corporation shares fell 29%, reshaping valuations as a $200 billion wafer fabrication boom boosts outlook. Click ...

Ionis Pharmaceuticals, Inc. is a long-term buy as launches, royalties, & pipeline growth boost revenue prospects despite cash ...

Analysts see investors rotating out of AI and tech into defensive sectors such as consumer staples and healthcare amid capex ...

Genmab (GMAB) and Incyte (INCY) announced a clinical trial collaboration to evaluate a combination of their experimental ...

Netflix remains a strong buy, with fundamentals overshadowed by negative sentiment and a 40% share price decline over the ...

Stock market recap: bank earnings, hotter CPI, tech weakness, and key movers like Meta, Netflix, Tesla, and IBM.

Wall Street investors expecting a rally after the November midterm elections may be disappointed, according to BTIG ...